US Activist Investors’ Aggressive Strategies are Starting to Force Change in Europe (CNBC) A recent example of activist success in Europe came on Monday......
(read more)July 30 - Hedge Funds, Insider Trading - Comments
Steven Cohen’s Venture Capital Firm Gets Into Crypto With New Partner (Fortune.com) Hedge fund billionaire Steve Cohen is joining the Bitcoin party......
(read more)July 12 - Hedge Funds, Insider Trading - Comments
Adage’s $30 Billion Hedge Fund Is Said to Gain 23.6% Last Year (Bloomberg) Adage Capital Management, a $30 billion hedge fund founded by two former......
(read more)February 23 - Hedge Funds, Insider Trading - Comments
Watch Leon Cooperman’s Biggest Positions Get Hit (CNBC) The vultures were circling Leon Cooperman‘s biggest positions after the SEC announced......
(read more)September 21 - Hedge Funds - Comments
Ackman’s Pershing Square Holdings gains 5.8 percent in August (Reuters) Billionaire investor William Ackman‘s portfolios climbed nearly 6......
(read more)September 2 - Hedge Funds - Comments
Pershing Square: An Update on Herbalife and Second Quarter Results (The Wall Street Journal) Pershing Square Holdings, the publicly traded security of......
(read more)July 20 - Hedge Funds - Comments
We are seeing a boatload of 13G filing activity at the moment and investment firms disclose their positions as of the end of 2015 (we are not publishing......
(read more)February 12 - Hedge Funds, News - Comments
SAGE Therapeutics Inc (NASDAQ:SAGE) has recently been included in a filing by Jacob Gottlieb‘s Visium Asset Management. According to the 13G filing......
(read more)February 11 - Hedge Funds, News - Comments
Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September......
(read more)December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than......
(read more)December 1 - Hedge Funds, News - Comments
Is it a good time to buy shares of Ascendis Pharma A/S (NASDAQ:ASND)? Jacob Gottlieb thinks so, since his fund, Visium Asset Management, has significantly......
(read more)September 1 - Hedge Funds, News - Comments
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV......
(read more)August 11 - Hedge Funds, News - Comments
Jacob Gottlieb is the manager and founder of Visium Asset Management. The fund was formed back in 2005 in New York, and since then it has raised its assets......
(read more)July 1 - Hedge Funds, News - Comments
Visium Asset Management has submitted its 13F filing with the SEC for the reporting period of March 31. The fund was founded in 2005 by Jacob Gottlieb......
(read more)May 29 - Hedge Funds, News - Comments
Jacob Gottlieb’s Visium Asset Management, Richard Gerson and Navroz D. Udwadia’s Falcon Edge Capital, and Richard Barrera’s Roystone Capital Management......
(read more)April 29 - Hedge Funds, News - Comments
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported......
(read more)April 10 - Hedge Funds, News - Comments
Stocks in the biotechnology industry have been very active as of late, with companies’ shares registering significant gains. The industry jumped......
(read more)March 31 - Hedge Funds, News - Comments
Jacob Gottlieb‘s Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the......
(read more)March 3 - Hedge Funds, News - Comments
Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares......
(read more)December 5 - Hedge Funds, News - Comments
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific......
(read more)October 20 - Hedge Funds, News - Comments
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with......
(read more)October 7 - Hedge Funds, News - Comments
Two Schedule 13G forms filed with the SEC yesterday called my attention. One of them was presented by Jacob Gottlieb’s Visium Asset Management, which......
(read more)October 3 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has boosted its stake in CONMED Corporation (NASDAQ:CNMD). In a new filing with the U.S. Securities......
(read more)September 23 - Hedge Funds, News - Comments
Wright Medical Group Inc (NASDAQ:WMGI)‘s stake in Jacob Gottlieb‘s Visium Asset Management’s equity portfolio has been slightly increased......
(read more)September 12 - Hedge Funds, News - Comments
In a new round of filing with the Securities and Exchange Commission, Huber Capital Management has disclosed the acquisition of some more Cal Dive International......
(read more)September 11 - Hedge Funds, News - Comments
Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in......
(read more)August 21 - Hedge Funds, News - Comments
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.......
(read more)August 11 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has boosted its position in Horizon Pharma Inc. (NASDAQ:HZNP), a new filing with the U.S. Securities......
(read more)August 11 - Hedge Funds, News - Comments
Jacob Gottlieb is very bullish on The Spectranetics Corporation (NASDAQ:SPNC) and has increased his fund’s stake by more than 300%, as reported......
(read more)July 25 - Hedge Funds, News - Comments
Jacob Gottlieb thinks OHR Pharmaceutical Inc (NASDAQ:OHRP) is a good investment and has initiated a new position for his fund, Visium Asset Management......
(read more)July 14 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, has disclosed a new position in Quotient Ltd (NASDAQ:QTNT). A new filing with the U.S. Securities......
(read more)June 30 - Hedge Funds, News - Comments
In the latest round of 13F filings, last week, Israel Englander’s Millennium Management has filed its form 13F with the U.S. Securities and Exchange......
(read more)May 20 - Hedge Funds, News - Comments
Jacob Gottlieb and his fund, Visium Asset Management, have upped their interest in Brookdale Senior Living, Inc. (NYSE:BKD) having increased their stake......
(read more)April 23 - Hedge Funds, News - Comments
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals......
(read more)April 17 - Hedge Funds, News - Comments
Coliseum Capital, managed by Christopher Shackelton and Adam Gray, has disclosed a new 6.2% stake in Medifast Inc (NYSE:MED). The position amasses 813......
(read more)March 19 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX). RA Capital has disclosed a passive......
(read more)March 19 - Hedge Funds, News - Comments
Steven Cohen of S.A.C Capital Advisors has increased its passive stake in Annie’s Inc (NYSE:BNNY), a recent 13G filing shows. Mr. Cohen raised......
(read more)March 17 - Hedge Funds, News - Comments
Steven Cohen’s SAC Capital Advisors has reported adding Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to its equity portfolio. SAC Capital Advisors currently......
(read more)March 13 - Hedge Funds, News - Comments
John Paulson reinforces his bullish views on Enzymotec Ltd (NASDAQ:ENZY). A recent 13G filing shows that his fund, Paulson & Co, more than doubled......
(read more)March 11 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc. (......
(read more)March 7 - Hedge Funds, News - Comments
Visium Asset Management, led by Jacob Gottlieb, has added NephroGenex Inc (NASDAQ:NRX) and Ignyta Inc (OTCBB:RXDX) to its equity portfolio. According......
(read more)February 21 - Hedge Funds, News - Comments
Citadel Investment Group, managed by Ken Griffin, has revealed, in a couple of new filings with the Securities and Exchange Commission tweaking its holdings......
(read more)February 4 - Hedge Funds, News - Comments
Kevin C. Tang‘s Tang Capital Management has decreased its position it two pharmaceutical companies. The $200 million hedge fund recently decreased......
(read more)January 17 - Hedge Funds, News - Comments
Jacob Gottlieb‘s Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing......
(read more)January 10 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......
(read more)January 2 - Hedge Funds, News - Comments
The position of Zogenix, Inc. (NASDAQ:ZGNX), in the equity portfolio of Jacob Gottlieb‘s Visium Asset Management has surged to over 8.9 million......
(read more)November 29 - Hedge Funds, News - Comments
Over the past week, insider activity at two pharmaceutical companies, IDEXX Laboratories, Inc. (NASDAQ:IDXX) and Onconova Therapeutics Inc (NASDAQ:ONTX......
(read more)November 26 - Insider Trading, News - Comments
Jacob Gottlieb‘s hedge fund, Visium Asset Management, has boosted its position in biotechnology company QLT Inc. (USA) (NASDAQ:QLTI), a new filing......
(read more)November 25 - Hedge Funds, News - Comments
Jacob Gottlieb, MEI Pharma: A couple of minutes ago, Jacob Gottlieb‘s hedge fund Visium Asset Management reported initiating a new position in......
(read more)October 16 - Hedge Funds, News - Comments
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of......
(read more)October 14 - Insider Trading, News - Comments
